Ernexa Therapeutics Inc. Company Profile
NASDAQ: ERNAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ernexa Therapeutics at a glance
Ernexa Therapeutics Inc. (NASDAQ: ERNA) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Cambridge, MA. Ernexa Therapeutics is led by Mr. Sanjeev Luther and employs about 5 people. At a market capitalization of $2.3 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0000748592, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Ernexa Therapeutics do?
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Ernexa Therapeutics Inc.
- Ticker
- NASDAQ: ERNA
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Sanjeev Luther
- Employees
- 5
- Headquarters
- 1035 Cambridge Street, Cambridge, MA, United States
- Phone
- 617 798 6700
- Website
- ernexatx.com
- Market cap
- $2.30M
- SEC CIK
- 0000748592
- Latest annual report
- 10-K · Mar 13, 2026
Companies similar to Ernexa Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HCWBHCW Biologics Inc. | 0.7491 | +1.90% | $2.35M | vs ERNA |
| ONCOOnconetix Inc. | 2.89 | -8.54% | $2.37M | vs ERNA |
| LABTLakewood-Amedex Biotherapeutics Inc. | 0.2449 | +15.03% | $2.19M | vs ERNA |
| GRIGRI Bio Inc. | 1.12 | 0.00% | $2.45M | vs ERNA |
| RDHLRedhill Biopharma Ltd. ADR | 0.281 | -13.08% | $2.50M | vs ERNA |
| SXTP60 Degrees Pharmaceuticals Inc. | 0.4682 | -6.36% | $2.10M | vs ERNA |
| DRMADermata Therapeutics Inc. | 0.5095 | -4.23% | $2.51M | vs ERNA |
| KAPAKairos Pharma Ltd. | 0.4359 | -4.62% | $2.04M | vs ERNA |